Amyris Receives $21,700,000 New Funding Round

  • Feed Type
  • Date
    2/2/2015
  • Company Name
    Amyris
  • Mailing Address
    5885 Hollis Street Emeryville, CA 94608 USA
  • Company Description
    Amyris Biotechnologies (NASDAQ: AMRS) is positioning itself to become a leading provider of renewable specialty chemicals and transportation fuels worldwide. Our initial molecule, farnesene, can serve as the basis for a wide range of products, enabling us to optimize our product mix and reduce our exposure to any one end market.
  • Website
    http://www.amyris.com
  • Transaction Type
    Debt
  • Transaction Amount
    $21,700,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing – amended. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy